Podcast

Study: New BPH treatments demonstrate efficacy

Author(s):

Urology Times staff

The study encompassed the prostatic urethral lift (UroLift), water vapor thermal therapy (Rezum), and temporary implantable nitinol device (iTIND).

In this episode, Richard K. Lee, MD, MBA, discusses the recent European Urology Focus paper, New Endoscopic In-office Surgical Therapies for Benign Prostatic Hyperplasia: A Systematic Review, for which he served as senior author. Lee is an Associate Professor of Urology and Healthcare Policy & Research at Weill Cornell Medicine Department of Urology in New York City.

Related Videos
Blurred interior of hospital | Image Credit: © jakkapan - stock.adobe.com
Dean S. Elterman, MD, MSc, FRCSC, answers a question during a Zoom video interview
Blurred interior of hospital | Image Credit: © jakkapan - stock.adobe.com
Amy E. Krambeck, MD, answers a question during a Zoom video interview
Wayne Kuang, MD, answers a question during a Zoom video interview
Prostate illustration | Image Credit: © Judith - stock.adobe.com
Blur image of hospital corridor | Image Credit: © zephyr_p - stock.adobe.com
Wayne Kuang, MD, answers a question during a Zoom video interview
3d rendered illustration - bladder | Image Credit: © Sebastian Kaulitzki - stock.adobe.com
Related Content
Blur image of hospital corridor | Image Credit: © zephyr_p - stock.adobe.com
February 21st 2025

SoBPD: How many ways can you treat BPH or BPD?

Gopal H. Badlani, MD
"Sometimes, there is more than a single answer to a question; this certainly applies to patients with benign prostatic disease," writes Gopal H. Badlani, MD.
Episode 3 Podcast: Moving Toward a Patient-Centered Approach in NMIBC Management
February 11th 2025

Episode 3 Podcast: Moving Toward a Patient-Centered Approach in NMIBC Management

Max Kates, MD Neal Shore, MD, FACS Katie S. Murray, DO, MS
Panelists discuss the impact of long-term care in patients with non–muscle-invasive bladder cancer (NMIBC), considering the unique needs of specific patient groups and highlighting advancements in NMIBC treatment that may support better care experiences for patients.
FDA logo
January 1st 2025

2024 Urology Times pipeline report

Jason M. Broderick Hannah Clarke Brittany Lovely
Catch up on all the notable drug and device approvals in urology over the past year.
Episode 2 Podcast: Identifying Patients with Intermediate Risk in NMIBC
January 29th 2025

Episode 2 Podcast: Identifying Patients with Intermediate Risk in NMIBC

Max Kates, MD Neal Shore, MD, FACS Tom Jayram, MD
Panelists explore challenges in identification of intermediate risk patients and emphasize importance of risk stratification to improve outcomes in regards to NMIBC.
Phase 1/2 trial launches of Focal One robotic HIFU for BPH
October 9th 2024

Phase 1/2 trial launches of Focal One robotic HIFU for BPH

Hannah Clarke
“While there are other treatment options available for treating BPH, there remains a significant need for much less invasive treatment approaches that can preserve and protect the integrity of the urethra and other critical structures," says Ryan Rhodes.
Benign Prostatic Hyperplasia | Image Credit: © Judith - stock.adobe.com
October 8th 2024

Dr. Stephen Overholser shares his experience with Aquablation for BPH

Urology Times staff
"Aquablation is versatile. It can manage a very wide range of prostate sizes and shapes," says Stephen Overholser, MD.
© 2025 MJH Life Sciences

All rights reserved.